A Case of Cholangitis as a Nivolumab-Induced Immune-Related Adverse Event in a Patient with Pulmonary Metastasis After Surgery for Oral Cancer.

Autor: Fukuzawa, Satoshi, Yamagata, Kenji, Uchida, Fumihiko, Endo, Masato, Sakamoto, Noriaki, Bukawa, Hiroki
Zdroj: Journal of Maxillofacial & Oral Surgery; Aug2024, Vol. 23 Issue 4, p979-983, 5p
Abstrakt: We report a case of cholangitis, an immune-related adverse event (irAE), caused by the administration of nivolumab in a patient with lung metastasis of oral cancer. A 72-year-old man developed pulmonary metastasis after surgery for oral cancer. Hepatic enzyme abnormalities were observed after the second session of treatment, and irAE cholangitis was diagnosed based on the results of the blood test results and endoscopy findings. We suggested steroid treatment, but the patient refused it. Therefore, he was treated with ursodeoxycholic acid. The cholangitis gradually deteriorated, the patients' general condition worsened, and he died 169 days after the onset of cholangitis. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz: